Relationships between the presence of PNH-type cells and auto-Abs in patients recently diagnosed with AA and clinical significance of antimoesin Abs
| Patient . | Age, y . | Sex . | Severity . | PNH . | Anti-DRS-1 Ab . | Antimoesin Ab . | Response to IST . | IST . |
|---|---|---|---|---|---|---|---|---|
| 1 | 25 | Male | M | + | + | + | + | ATG + CsA |
| 2 | 29 | Female | M | + | + | + | + | ATG + CsA |
| 3 | 60 | Male | M | + | + | + | + | ATG + CsA |
| 4 | 64 | Female | S | + | + | + | + | ATG + CsA |
| 5 | 66 | Female | M | + | + | + | + | ATG + CsA |
| 6 | 73 | Female | M | + | + | + | + | ATG + CsA |
| 7 | 49 | Male | S | + | + | + | − | ATG + CsA |
| 8 | 66 | Male | M | + | + | − | + | ATG + CsA |
| 9 | 17 | Male | M | + | − | + | + | ATG + CsA |
| 10 | 73 | Male | S | + | − | + | + | ATG + CsA |
| 11 | 72 | Male | M | + | − | + | − | ATG + CsA |
| 12 | 22 | Male | S | + | − | − | + | ATG + CsA |
| 13 | 62 | Male | S | + | − | − | + | ATG + CsA |
| 14 | 83 | Female | S | + | − | − | + | ATG + CsA |
| 15 | 23 | Male | S | − | + | − | − | ATG + CsA |
| 16 | 63 | Male | M | − | − | + | + | ATG + CsA |
| 17 | 77 | Female | S | − | − | + | − | ATG + CsA |
| 18 | 28 | Male | M | − | − | − | − | ATG + CsA |
| 19 | 34 | Female | M | + | + | + | + | CsA |
| 20 | 42 | Male | M | + | + | + | + | CsA |
| 21 | 74 | Female | S | + | + | + | + | CsA |
| 22 | 78 | Female | M | + | + | + | + | CsA |
| 23 | 70 | Female | M | + | + | − | + | CsA |
| 24 | 75 | Female | M | + | − | + | + | CsA |
| 25 | 47 | Female | M | + | − | − | + | CsA |
| 26 | 79 | Male | M | + | − | − | + | CsA |
| 27 | 43 | Female | M | − | − | + | + | CsA |
| 28 | 39 | Female | M | − | − | − | − | CsA |
| Patient . | Age, y . | Sex . | Severity . | PNH . | Anti-DRS-1 Ab . | Antimoesin Ab . | Response to IST . | IST . |
|---|---|---|---|---|---|---|---|---|
| 1 | 25 | Male | M | + | + | + | + | ATG + CsA |
| 2 | 29 | Female | M | + | + | + | + | ATG + CsA |
| 3 | 60 | Male | M | + | + | + | + | ATG + CsA |
| 4 | 64 | Female | S | + | + | + | + | ATG + CsA |
| 5 | 66 | Female | M | + | + | + | + | ATG + CsA |
| 6 | 73 | Female | M | + | + | + | + | ATG + CsA |
| 7 | 49 | Male | S | + | + | + | − | ATG + CsA |
| 8 | 66 | Male | M | + | + | − | + | ATG + CsA |
| 9 | 17 | Male | M | + | − | + | + | ATG + CsA |
| 10 | 73 | Male | S | + | − | + | + | ATG + CsA |
| 11 | 72 | Male | M | + | − | + | − | ATG + CsA |
| 12 | 22 | Male | S | + | − | − | + | ATG + CsA |
| 13 | 62 | Male | S | + | − | − | + | ATG + CsA |
| 14 | 83 | Female | S | + | − | − | + | ATG + CsA |
| 15 | 23 | Male | S | − | + | − | − | ATG + CsA |
| 16 | 63 | Male | M | − | − | + | + | ATG + CsA |
| 17 | 77 | Female | S | − | − | + | − | ATG + CsA |
| 18 | 28 | Male | M | − | − | − | − | ATG + CsA |
| 19 | 34 | Female | M | + | + | + | + | CsA |
| 20 | 42 | Male | M | + | + | + | + | CsA |
| 21 | 74 | Female | S | + | + | + | + | CsA |
| 22 | 78 | Female | M | + | + | + | + | CsA |
| 23 | 70 | Female | M | + | + | − | + | CsA |
| 24 | 75 | Female | M | + | − | + | + | CsA |
| 25 | 47 | Female | M | + | − | − | + | CsA |
| 26 | 79 | Male | M | + | − | − | + | CsA |
| 27 | 43 | Female | M | − | − | + | + | CsA |
| 28 | 39 | Female | M | − | − | − | − | CsA |
M indicates moderate; S, severe; +, positive; and –, negative.